Northrop Grumman’s stock softness raises a familiar question: is valuation still attractive?

Northrop Grumman (NYSE: NOC) is being tested again on valuation after a period of share-price softness, according to a Yahoo Finance column published June 2, 2026. The article discussed the idea of whether NOC’s strengths are already reflected in the stock after it was trading around about $539 per share at the time of publication. At issue for market participants is the balance between defense-contract momentum and the reality that premium pricing can limit upside even when operating performance stays solid.

NOC’s recent filings point to continuing demand. In its 2025 proxy statement, the company reported record backlog of $95.7 billion at December 31, 2025, describing backlog as remaining work under customer agreements. The same proxy summary said 2025 sales were $42 billion, operating margin was 10.8%, and free cash flow was $3.3 billion, alongside a 12% quarterly dividend increase (its 22nd consecutive annual dividend increase).

More near-term operating detail came from Northrop’s first-quarter 2026 results. In an April 21, 2026 earnings release, the company said it reached agreements with the U.S. Air Force to increase B-21 production capacity and accelerate Sentinel initial operating capability. The release also cited continued demand, with net awards of $9.8 billion and backlog of about $95.6 billion. First-quarter sales rose 4% to $9.9 billion, and the company reported an operating margin rate of 10.0% and diluted earnings per share of $6.14.

Even with this backlog support, the financial results show how program-level timing can still matter. In the same first-quarter release, Northrop highlighted that operating performance was helped by the absence of a prior-year B-21 loss provision, and it pointed to specific segment movements, including a wind-down effect on the Next Generation Interceptor (NGI) program within Space Systems. That mix is important for investors trying to judge whether reported earnings translate into steady cash generation over multiple quarters, rather than stronger results driven by one-time comparisons.

On valuation, market data compiled by StockAnalysis suggests NOC was trading at a trailing price-to-earnings multiple of 17.04 and a forward multiple of 19.22, along with a dividend yield around 1.70%. Those figures do not resolve the debate raised by the Yahoo column, but they frame it. A defense contractor with a large backlog can still trade like a mature, fairly valued cash-flow story rather than a pure growth play, especially when expectations for execution are already high.

Company-specific context also matters for how shareholders interpret “softness.” Defense prime contractors can see investor sentiment shift quickly with changes in procurement schedules, contract awards, and margin drivers tied to major programs. Northrop’s disclosures underline that such drivers exist across its portfolio, even while total backlog remains very large.

The key uncertainty is what the market is discounting. The Yahoo column’s thesis is about whether the stock price already reflects NOC’s strengths, but it does not change what the company has to deliver next: execution against major programs like B-21 and Sentinel, continued conversion of backlog into revenue, and sustained free cash flow. Northrop, for its part, has not offered any valuation-targeting guidance in the disclosures reviewed here, so the “entry point” question largely remains an investor-by-investor judgment tied to assumptions about duration of demand and program performance.

What to watch next is therefore straightforward but consequential: Northrop’s next quarterly earnings update, any additional contract awards and backlog movement beyond the roughly $95.6 billion level reported for the first quarter, and management’s continued commentary on pacing for B-21 production and other large programs. If results stay aligned with recent operating margin trends and cash generation remains steady, it would support the view that the valuation reset from recent softness is temporary. If margin or cash flow volatility increases due to program timing, investors may continue to treat dips in NOC’s share price as caution indicates rather than opportunities.